New drug combo tested for Tough-to-Treat blood cancer
Disease control
Recruiting now
This study is testing a new drug called F182112, given in different combination schedules, for people with multiple myeloma that has come back or stopped responding to prior treatments. It aims to see how well the treatment works and how safe it is. The study will enroll about 90…
Phase: PHASE2 • Sponsor: Shandong New Time Pharmaceutical Co., LTD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC